Cancer-Induced Fatigue and Cachexia

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-319-28558-0_8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation.

  2014cited by this paper
• Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

  2014cited by this paper
• Cancer-related fatigue—mechanisms, risk factors, and treatments

  2014cited by this paper
• Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

  2013cited by this paper
• Regulation of TNF‐α with a focus on rheumatoid arthritis

  2013cited by this paper
• Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study.

  2012cited by this paper
• Non-canonical ubiquitin-based signals for proteasomal degradation

  2012cited by this paper
• Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.

  2012cited by this paper
• Cancer‐related fatigue

  2012cited by this paper
• The unfolded protein response: controlling cell fate decisions under ER stress and beyond

  2012cited by this paper
• Nutritional interventions for cancer-induced cachexia.

  2011cited by this paper
• Interplay between FOXO, TOR, and Akt.

  2011cited by this paper
• Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.

  2011cited by this paper
• Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue.

  2011cited by this paper
• Molecular Bases of Cyclic and Specific Disulfide Interchange between Human ERO1α Protein and Protein-disulfide Isomerase (PDI)*

  2011cited by this paper
• Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis

  2011cited by this paper
• Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics.

  2010cited by this paper
• TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion

  2010cited by this paper
• Reactive oxygen species and uncoupling protein 2 in pancreatic β‐cell function

  2010cited by this paper
• Proteasomal recognition of ubiquitylated substrates.

  2010cited by this paper
• The ubiquitin–26S proteasome system at the nexus of plant biology

  2009cited by this paper
• Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise.

  2009cited by this paper
• Wishing away inflammation? New links between serotonin and TNF signaling.

  2009cited by this paper
• Proton Speciation and Microspeciation of Serotonin and 5‐Hydroxytryptophan

  2009cited by this paper
• Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?

  2009cited by this paper
• The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator?

  2008cited by this paper
• UCP2 is highly expressed in pancreatic α-cells and influences secretion and survival

  2008cited by this paper
• Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin

  2008cited by this paper
• Free radicals and muscle fatigue: Of ROS, canaries, and the IOC.

  2008cited by this paper
• TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme

  2008cited by this paper
• TNF: a master switch for inflammation to cancer.

  2008cited by this paper
• The role of microenvironment in tumor angiogenesis

  2008cited by this paper
• Transforming growth factor-β and myostatin signaling in skeletal muscle

  2008cited by this paper
• Causes and Consequences of Increased Glucose Metabolism of Cancers

  2008cited by this paper
• HIF-1 regulation: not so easy come, easy go.

  2008cited by this paper
• Hypoxia-induced reactive oxygen species formation in skeletal muscle.

  2007cited by this paper
• Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.

  2007cited by this paper
• Translational Control and the Unfolded Protein Response

  2007cited by this paper
• Mechanisms of cancer-related fatigue.

  2007cited by this paper
• Serotonin Activates the Hypothalamic–Pituitary–Adrenal Axis via Serotonin 2C Receptor Stimulation

  2007cited by this paper
• Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFκB Activation Pathways Bifurcate at IL-1 Receptor-associated Kinase Modification*

  2007cited by this paper
• Mechanisms of hypoxic signal transduction regulated by reactive nitrogen species

  2007cited by this paper
• Exercise, serum free tryptophan, and central fatigue.

  2006cited by this paper
• A role for branched-chain amino acids in reducing central fatigue.

  2006cited by this paper
• Central Fatigue

  2006cited by this paper
• Site-specific Lys-63-linked Tumor Necrosis Factor Receptor-associated Factor 6 Auto-ubiquitination Is a Critical Determinant of IκB Kinase Activation*

  2006cited by this paper
• The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin.

  2006cited by this paper
• The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats.

  2006cited by this paper
• An open‐label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed‐site cancer patients and their partners

  2006cited by this paper
• Integrin α2-mediated ERK and Calpain Activation Play a Critical Role in Cell Adhesion and Motility via Focal Adhesion Kinase Signaling

  2006cited by this paper
• Diurnal cortisol rhythm and fatigue in breast cancer survivors.

  2005cited by this paper
• Effects of interferon-γ, interleukin-1β, and tumor necrosis factor-α on the serotonin metabolism in the nucleus raphe dorsalis of the rat

  2005cited by this paper
• Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.

  2005cited by this paper
• Interleukin-6 Causes Myocardial Failure and Skeletal Muscle Atrophy in Rats

  2005cited by this paper
• Neuroanatomic correlates of psychopathologic components of major depressive disorder.

  2005cited by this paper
• Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44.

  2005cited by this paper
• Adrenal corticosteroid biosynthesis, metabolism, and action.

  2005cited by this paper
• IL-6-induced skeletal muscle atrophy.

  2005cited by this paper
• Endoplasmic reticulum stress: cell life and death decisions.

  2005cited by this paper
• Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635.

  2005cited by this paper
• Altered Cortisol Response to Psychologic Stress in Breast Cancer Survivors With Persistent Fatigue

  2005cited by this paper
• Mechanisms of disuse muscle atrophy: role of oxidative stress.

  2005cited by this paper
• l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

  2005cited by this paper
• CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum.

  2004cited by this paper
• The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

  2004cited by this paper
• Cancer patients' expectations of experiencing treatment‐related side effects

  2004cited by this paper
• Getting into position: the catalytic mechanisms of protein ubiquitylation.

  2004cited by this paper
• Structural insights into the regulatory mechanism of IP3 receptor.

  2004cited by this paper
• Cytokines and psychopathology: lessons from interferon-alpha.

  2004cited by this paper
• The Role of Interleukin 1 Receptor-associated Kinase-4 (IRAK-4) Kinase Activity in IRAK-4-mediated Signaling*

  2004cited by this paper
• Inhibition of MAP/ERK kinase prevents IGF-I-induced hypertrophy in rat muscles.

  2004cited by this paper
• Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy

  2004cited by this paper
• Sequential Autophosphorylation Steps in the Interleukin-1 Receptor-associated Kinase-1 Regulate its Availability as an Adapter in Interleukin-1 Signaling*

  2004cited by this paper
• The ubiquitin 26S proteasome proteolytic pathway.

  2004cited by this paper
• Superoxide Activates Uncoupling Proteins by Generating Carbon-centered Radicals and Initiating Lipid Peroxidation

  2003cited by this paper
• Mitochondrial formation of reactive oxygen species

  2003cited by this paper
• Phosphatases in cell–matrix adhesion and migration

  2003cited by this paper
• Thiol‐mediated protein retention in the endoplasmic reticulum: the role of ERp44

  2003cited by this paper
• Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases.

  2003cited by this paper
• Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program.

  2003cited by this paper
• Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

  2003cited by this paper
• FAK regulates biological processes important for the pathogenesis of cancer

  2003cited by this paper
• Tumor necrosis factor signaling

  2003cited by this paper
• Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors

  2002cited by this paper
• Fatigue associated with cancer and its treatment

  2002cited by this paper
• Suppressors of cytokine signalling (SOCS) in the immune system

  2002cited by this paper
• Muscle fatigue: lactic acid or inorganic phosphate the major cause?

  2002cited by this paper
• Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip*

  2002cited by this paper
• Interleukin-1 (IL-1) Receptor-Associated Kinase-Dependent IL-1-Induced Signaling Complexes Phosphorylate TAK1 and TAB2 at the Plasma Membrane and Activate TAK1 in the Cytosol

  2002cited by this paper
• Distinct molecular mechanism for initiating TRAF6 signalling

  2002cited by this paper
• TAK1 is a ubiquitin-dependent kinase of MKK and IKK

  2001cited by this paper
• Muscle Cachexia: Current Concepts of Intracellular Mechanisms and Molecular Regulation

  2001cited by this paper
• IRAK-mediated Translocation of TRAF6 and TAB2 in the Interleukin-1-induced Activation of NFκB*

  2001cited by this paper
• Cytokine‐Induced Sickness Behavior: Mechanisms and Implications

  2001cited by this paper
• Acute interferon-α administration modulates sucrose consumption in the rat

  2001cited by this paper
• Effect of interferon-α on tyrosine hydroxylase and catecholamine levels in the brain of rats

  2000cited by this paper
• Fatique Patterns Observed in Patients Receiving Chemotherapy and Radiotherapy

  2000cited by this paper
• Serotonin and central nervous system fatigue: nutritional considerations.

  2000cited by this paper
• Perk is essential for translational regulation and cell survival during the unfolded protein response.

  2000cited by this paper
• A critical step in metastasis: in vivo analysis of intravasation at the primary tumor.

  2000cited by this paper

• No citing papers are available for this paper.